The Association Between Allergy Skin Testing, Atopic Respiratory Conditions, and Stroke Mortality in Middle-Aged and Elderly Adults

References

1. ↵
   Heron M. Deaths: leading causes for 2004. Natl Vital Stat Rep 2007; 56: 1–95.

   OpenUrlPubMed
2. ↵
   Rosamond W, Flegal K, Friday G, et al. Heart disease and stroke statistics–2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115: e69–171.

   OpenUrlFREE Full Text
3. ↵
   Chambless LE, Heiss G, Shahar E, Earp MJ, Toole J. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2004; 160: 259–69.

   OpenUrlAbstract/FREE Full Text
4. ↵
   Schanen JG, Iribarren C, Shahar E, et al. Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study. Thorax 2005; 60: 633–8.

   OpenUrlAbstract/FREE Full Text
5. ↵
   Matheson EM, Player MS, Mainous AG 3rd, King DE, Everett CJ. The association between hay fever and stroke in a cohort of middle-aged and elderly adults. J Am Board Fam Med 2008; 21: 179–83.

   OpenUrlAbstract/FREE Full Text
6. ↵
   McDowell A, Engel A, Massey JT, Maurer K. Plan and operation of the Second National Health and Nutrition Examination Survey, 1976–1980. Vital Health Stat 1. 1981; 15: 1–144.

   OpenUrl
7. ↵
   Loria CM, Sempos CT, Vuong C. Plan and operation of the NHANES II Mortality Study, 1992. Vital Health Stat 1 1999; 38: 1–16.

   OpenUrl
8. ↵
   Stampfer MJ, Willett WC, Speizer FE, et al. Test of the National Death Index. Am J Epidemiol 1984; 119: 837–9.

   OpenUrlFREE Full Text
9. ↵
   Williams BC, Demitrack LB, Fries BE. The accuracy of the National Death Index when personal identifiers other than Social Security number are used. Am J Public Health 1992; 82: 1145–7.

   OpenUrlCrossRefPubMedWeb of Science
10. ↵
    Marini C, Totaro R, De Santis F, Ciancarelli I, Baldassarre M, Carolei A. Stroke in young adults in the community-based L'Aquila registry: incidence and prognosis. Stroke 2001; 32: 52–6.

    OpenUrlAbstract/FREE Full Text
11. ↵
    National Health and Nutrition Examination Survey. Public use data tape documentation: allergy skin testing tape 5309. National Health and Nutrition Examination Survey, 1976–1980: 101–5.
12. ↵
    Seshadri S, Beiser A, Kelly-Hayes M, et al. The lifetime risk of stroke: estimates from the Framingham Study. Stroke 2006; 37: 345–50.

    OpenUrlAbstract/FREE Full Text
13. Centers for Disease Control and Prevention. Age-specific excess deaths associated with stroke among racial/ethnic minority populations–United States, 1997. JAMA 2000; 283: 2382–3.

    OpenUrlCrossRefPubMed
14. Ueshima H, Choudhury SR, Okayama A, et al. Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke 2004; 35: 1836–41.

    OpenUrlAbstract/FREE Full Text
15. Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med 2004; 164: 1422–6.

    OpenUrlCrossRefPubMedWeb of Science
16. Hansagi H, Romelsjo A, Gerhardsson de Verdier M, Andreasson S, Leifman A. Alcohol consumption and stroke mortality. 20-year follow-up of 15,077 men and women. Stroke. 1995; 26: 1768–73.

    OpenUrlAbstract/FREE Full Text
17. ↵
    Straus SE, Majumdar SR, McAlister FA. New evidence for stroke prevention: clinical applications. JAMA 2002; 288: 1396–8.

    OpenUrlCrossRefPubMedWeb of Science
18. ↵
    Gergen PJ, Turkeltaub PC, Sempos CT. Is allergen skin test reactivity a predictor of mortality? Findings from a national cohort. Clin Exp Allergy 2000; 30: 1717–23.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991; 22: 312–8.

    OpenUrlAbstract/FREE Full Text
20. ↵
    Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982; 69: 239–41.

    OpenUrlAbstract/FREE Full Text
21. ↵
    Braunstahl GJ, Fokkens WJ, Overbeek SE, KleinJan A, Hoogsteden HC, Prins JB. Mucosal and systemic inflammatory changes in allergic rhinitis and asthma: a comparison between upper and lower airways. Clin Exp Allergy 2003; 33: 579–87.

    OpenUrlCrossRefPubMedWeb of Science
22. ↵
    Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034–41.

    OpenUrlCrossRefPubMedWeb of Science
23. ↵
    Magen E, Yosefy C, Viskoper RJ, Mishal J. Treatment of allergic rhinitis can improve blood pressure control. J Hum Hypertens 2006; 20: 888–93.

    OpenUrlPubMed
24. ↵
    Kony S, Zureik M, Neukirch C, Leynaert B, Vervloet D, Neukirch F. Rhinitis is associated with increased systolic blood pressure in men: a population-based study. Am J Respir Crit Care Med 2003; 167: 538–43.

    OpenUrlCrossRefPubMedWeb of Science
25. ↵
    Guilleminault C, Stoohs R, Shiomi T, Kushida C, Schnittger I. Upper airway resistance syndrome, nocturnal blood pressure monitoring, and borderline hypertension. Chest 1996; 109: 901–8.

    OpenUrlCrossRefPubMedWeb of Science
26. ↵
    Guilleminault C, Chowdhuri S. Upper airway resistance syndrome is a distinct syndrome. Am J Respir Crit Care Med 2000; 161: 1412–3.

    OpenUrlPubMedWeb of Science
27. ↵
    Hoshi T, Kitagawa K, Yamagami H, Furukado S, Hougaku H, Hori M. Relation between interleukin-6 level and subclinical intracranial large-artery atherosclerosis. Atherosclerosis 2008; 197: 326–32.

    OpenUrlCrossRefPubMed
28. Cesari M, Penninx BW, Newman AB, et al. Inflammatory markers and onset of cardiovascular events: results from the Health ABC study. Circulation 2003; 108: 2317–22.

    OpenUrlAbstract/FREE Full Text
29. van Exel E, Gussekloo J, de Craen AJ, Bootsma-van der Wiel A, Frolich M, Westendorp RG. Inflammation and stroke: the Leiden 85-Plus Study. Stroke 2002; 33: 1135–8.

    OpenUrlAbstract/FREE Full Text
30. Mallat Z, Besnard S, Duriez M, et al. Protective role of interleukin-10 in atherosclerosis. Circ Res 1999; 85: e17–24.

    OpenUrlPubMedWeb of Science
31. Cipollone F, Mezzetti A, Fazia ML, et al. Association between 5-lipoxygenase expression and plaque instability in humans. Arterioscler Thromb Vasc Biol 2005; 25: 1665–70.

    OpenUrlAbstract/FREE Full Text
32. Klemens C, Rasp G, Jund F, et al. Mediators and cytokines in allergic and viral-triggered rhinitis. Allergy Asthma Proc 2007; 28: 434–41.

    OpenUrlPubMed
33. ↵
    Krishnamoorthy N, Oriss TB, Paglia M, et ak. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med 2008; 14: 565–73.

    OpenUrlCrossRefPubMedWeb of Science
34. Heaton T, Rowe J, Turner S, et al. An immunoepidemiological approach to asthma: identification of in-vitro T-cell response patterns associated with different wheezing phenotypes in children. Lancet 2005; 365: 142–9.

    OpenUrlCrossRefPubMedWeb of Science
35. Enrique E, Pineda F, Malek T, et al. Sublingual immunotherapy for hazelnut food allergy: a randomized, double-blind, placebo-controlled study with a standardized hazelnut extract. J Allergy Clin Immuno 2005; 116: 1073–9.

    OpenUrlCrossRefPubMedWeb of Science
36. Allayee H, Hartiala J, Lee W, et al. The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. Chest 2007; 132: 868–74.

    OpenUrlCrossRefPubMed